title: BCL2A1: the underdog in the BCL2 family.
abstract: B-cell lymphoma 2 (BCL2) proteins are important cell death regulators, whose main function is to control the release of cytochrome c from mitochondria in the intrinsic apoptotic pathway. They comprise both pro- and anti-apoptotic proteins, which interact in various ways to induce or prevent pore formation in the outer mitochondrial membrane. Due to their central function in the apoptotic machinery, BCL2 proteins are often deregulated in cancer. To this end, many anti-apoptotic BCL2 proteins have been identified as important cellular oncogenes and attractive targets for anti-cancer therapy. In this review, the existing knowledge on B-cell lymphoma 2-related protein A1 (BCL2A1)/Bcl-2-related gene expressed in fetal liver (Bfl-1), one of the less extensively studied anti-apoptotic BCL2 proteins, is summarized. BCL2A1 is a highly regulated nuclear factor κB (NF-κB) target gene that exerts important pro-survival functions. In a physiological context, BCL2A1 is mainly expressed in the hematopoietic system, where it facilitates survival of selected leukocytes subsets and inflammation. However, BCL2A1 is overexpressed in a variety of cancer cells, including hematological malignancies and solid tumors, and may contribute to tumor progression. Therefore, the development of small molecule inhibitors of BCL2A1 may be a promising approach mainly to sensitize tumor cells for apoptosis and thus improve the efficiency of anti-cancer therapy.
authors.affiliation: MRC Toxicology Unit, University of Leicester, Leicester, UK. mv62@le.ac.uk
authors.forename: M
authors.initials: M
authors.lastname: Vogler
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation; D006801:Humans; D051379:Mice; D015778:Minor Histocompatibility Antigens; D008969:Molecular Sequence Data; D016328:NF-kappa B / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D011485:Protein Binding; D011487:Protein Conformation; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D051017:Apoptosis Regulatory Proteins; C096816:BCL2-related protein A1; D015778:Minor Histocompatibility Antigens; D016328:NF-kappa B; D019253:Proto-Oncogene Proteins c-bcl-2
references.citation: Cancer Res. 1996 Sep 1;56(17):3879-82
references.pmid: 8752150
references.citation: Br J Haematol. 2004 May;125(3):373-82
references.pmid: 15086420
references.citation: J Clin Invest. 2006 Dec;116(12):3171-82
references.pmid: 17111047
references.citation: Allergy. 2006 Sep;61(9):1040-6
references.pmid: 16918505
references.citation: Int J Hematol. 2000 Dec;72(4):484-90
references.pmid: 11197217
references.citation: Mol Cell. 2005 Feb 4;17(3):393-403
references.pmid: 15694340
references.citation: J Dermatol. 2006 May;33(5):309-18
references.pmid: 16700662
references.citation: Blood. 2001 Jan 1;97(1):264-9
references.pmid: 11133770
references.citation: Int J Cancer. 2005 Feb 20;113(5):730-7
references.pmid: 15499630
references.citation: Mol Cancer Ther. 2009 Apr;8(4):904-13
references.pmid: 19372563
references.citation: Mamm Genome. 1997 Apr;8(4):293-4
references.pmid: 9096119
references.citation: Cancer Cell. 2008 Oct 7;14(4):285-98
references.pmid: 18835031
references.citation: Oncogene. 2004 Apr 1;23(14):2548-53
references.pmid: 14981542
references.citation: Cell. 2010 Mar 19;140(6):821-32
references.pmid: 20303873
references.citation: Int Immunol. 1999 Nov;11(11):1753-61
references.pmid: 10545479
references.citation: Mol Cell Biol. 1999 Sep;19(9):5923-9
references.pmid: 10454539
references.citation: Nature. 1997 Apr 3;386(6624):517-21
references.pmid: 9087414
references.citation: Blood. 2002 May 1;99(9):3350-9
references.pmid: 11964303
references.citation: Genes Dev. 2005 Jun 1;19(11):1294-305
references.pmid: 15901672
references.citation: J Immunol. 2004 Nov 15;173(10):5963-70
references.pmid: 15528330
references.citation: Mol Cancer Ther. 2008 Jun;7(6):1639-46
references.pmid: 18566235
references.citation: Bioorg Med Chem Lett. 2010 Nov 15;20(22):6560-4
references.pmid: 20933419
references.citation: Oncogene. 1997 Feb 27;14(8):997-1001
references.pmid: 9050999
references.citation: Mol Cell Biol. 2005 May;25(10):3896-905
references.pmid: 15870264
references.citation: Int Immunol. 1998 May;10(5):631-7
references.pmid: 9645611
references.citation: J Biol Chem. 1997 Jun 13;272(24):15547-52
references.pmid: 9182591
references.citation: Mamm Genome. 1997 Oct;8(10):781-2
references.pmid: 9321477
references.citation: Cell Regul. 1991 May;2(5):403-12
references.pmid: 1832565
references.citation: J Clin Immunol. 2008 May;28(3):250-5
references.pmid: 18071883
references.citation: Cell Death Differ. 2005 Sep;12(9):1225-39
references.pmid: 16094403
references.citation: Oncogene. 2007 Feb 26;26(9):1324-37
references.pmid: 17322918
references.citation: FEBS Lett. 2008 Oct 29;582(25-26):3590-4
references.pmid: 18812174
references.citation: Blood. 2005 Mar 1;105(5):1851-61
references.pmid: 15550490
references.citation: Nature. 1991 Jan 17;349(6306):254-6
references.pmid: 1987477
references.citation: J Clin Invest. 2005 Apr;115(4):1039-48
references.pmid: 15841185
references.citation: Br J Cancer. 2007 Sep 17;97(6):769-77
references.pmid: 17726463
references.citation: Structure. 2008 May;16(5):818-29
references.pmid: 18462686
references.citation: J Biol Chem. 2006 May 12;281(19):13663-13671
references.pmid: 16551634
references.citation: Leukemia. 2010 May;24(5):1073-6
references.pmid: 20200559
references.citation: BMC Med Genomics. 2008 Apr 28;1:13
references.pmid: 18442402
references.citation: Science. 1995 Mar 10;267(5203):1506-10
references.pmid: 7878471
references.citation: Int J Oncol. 2009 Aug;35(2):273-80
references.pmid: 19578740
references.citation: J Immunol. 1998 Jan 1;160(1):107-11
references.pmid: 9551962
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7834-8
references.pmid: 7644501
references.citation: J Korean Med Sci. 2003 Apr;18(2):225-30
references.pmid: 12692420
references.citation: Anticancer Res. 1997 Nov-Dec;17(6D):4619-22
references.pmid: 9494579
references.citation: Oncogene. 2003 Apr 24;22(16):2457-65
references.pmid: 12717423
references.citation: J Biol Chem. 2002 Jun 21;277(25):22781-8
references.pmid: 11929871
references.citation: J Immunol. 1999 Feb 1;162(3):1376-83
references.pmid: 9973392
references.citation: Oncogene. 2010 Sep 9;29(36):5071-82
references.pmid: 20581863
references.citation: World J Gastroenterol. 2009 Jan 21;15(3):356-65
references.pmid: 19140237
references.citation: Biol Reprod. 2002 May;66(5):1471-6
references.pmid: 11967212
references.citation: J Exp Med. 2005 Feb 21;201(4):603-14
references.pmid: 15728238
references.citation: Genes Dev. 1999 Feb 15;13(4):400-11
references.pmid: 10049356
references.citation: Cancer Res. 2008 May 1;68(9):3421-8
references.pmid: 18451170
references.citation: Biochemistry. 2011 Jun 14;50(23):5120-9
references.pmid: 21563784
references.citation: Br J Haematol. 2004 Nov;127(4):404-15
references.pmid: 15521917
references.citation: Nature. 2010 Feb 18;463(7283):899-905
references.pmid: 20164920
references.citation: J Exp Med. 2001 Dec 3;194(11):1561-69
references.pmid: 11733571
references.citation: Cell Death Differ. 2009 Mar;16(3):360-7
references.pmid: 18806758
references.citation: Nat Rev Mol Cell Biol. 2008 Jan;9(1):47-59
references.pmid: 18097445
references.citation: Cancer Cell. 2006 May;9(5):351-65
references.pmid: 16697956
references.citation: Int J Biochem Cell Biol. 2011 Apr;43(4):573-85
references.pmid: 21167304
references.citation: J Immunol. 1993 Aug 15;151(4):1979-88
references.pmid: 8345191
references.citation: Blood. 2010 Apr 29;115(17):3559-69
references.pmid: 20185581
references.citation: Mol Cancer Ther. 2005 Dec;4(12):1867-79
references.pmid: 16373702
references.citation: J Immunol. 2005 Dec 15;175(12):7916-29
references.pmid: 16339527
references.citation: J Biol Chem. 2009 Oct 30;284(44):30257-63
references.pmid: 19759007
references.citation: Blood. 2010 Apr 22;115(16):3304-13
references.pmid: 20197552
references.citation: Genes Dev. 1999 Feb 15;13(4):382-7
references.pmid: 10049353
references.citation: Br J Haematol. 2009 Apr;145(1):45-58
references.pmid: 19183193
references.citation: Oral Oncol. 2010 May;46(5):379-86
references.pmid: 20371203
references.citation: Oncogene. 2007 Aug 23;26(39):5828-32
references.pmid: 17353899
references.citation: Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9136-41
references.pmid: 10430908
references.citation: Blood. 2009 Apr 30;113(18):4403-13
references.pmid: 19008458
references.citation: J Exp Med. 1998 Dec 7;188(11):1985-92
references.pmid: 9841913
references.citation: Cell Death Differ. 2009 Jul;16(7):1030-9
references.pmid: 19390557
references.citation: Nature. 1997 Jul 10;388(6638):190-5
references.pmid: 9217161
references.citation: Blood. 2006 Jun 15;107(12):4695-702
references.pmid: 16484585
references.citation: Oncogene. 1995 Nov 2;11(9):1693-8
references.pmid: 7478596
references.citation: Oncogene. 2009 Mar 5;28(9):1274-9
references.pmid: 19137012
references.citation: J Biol Chem. 1996 Nov 1;271(44):27201-4
references.pmid: 8910286
references.citation: Oncogene. 2008 Feb 28;27(10):1421-8
references.pmid: 17724464
references.citation: Mol Cell. 2002 Aug;10(2):417-26
references.pmid: 12191486
references.citation: Oncogene. 2005 Feb 10;24(7):1252-61
references.pmid: 15592513
references.citation: Immunity. 2002 Jul;17(1):51-62
references.pmid: 12150891
references.citation: Cell Death Differ. 2003 Sep;10(9):1059-67
references.pmid: 12934080
references.citation: Blood. 2003 Apr 1;101(7):2679-85
references.pmid: 12406903
references.citation: Blood. 2000 Aug 15;96(4):1496-504
references.pmid: 10942397
references.citation: J Biol Chem. 2000 Apr 14;275(15):11092-9
references.pmid: 10753914
references.citation: Cell Death Differ. 2006 Aug;13(8):1325-38
references.pmid: 16645634
references.citation: Cancer Lett. 2004 Aug 20;212(1):61-70
references.pmid: 15246562
references.citation: Br J Haematol. 2003 Feb;120(3):434-41
references.pmid: 12580957
references.citation: Breast Cancer Res Treat. 2008 Jun;109(3):491-501
references.pmid: 17659439
references.citation: Genes Dev. 2000 Jan 1;14(1):23-7
references.pmid: 10640272
references.citation: Cell Immunol. 2000 Feb 25;200(1):56-62
references.pmid: 10716883
references.citation: J Immunol. 2002 Mar 1;168(5):2101-10
references.pmid: 11859095
references.citation: Cell Death Differ. 2006 Jul;13(7):1213-21
references.pmid: 16294210
references.citation: J Biol Chem. 2008 Apr 11;283(15):9580-6
references.pmid: 18178565
references.citation: Blood. 1996 Apr 15;87(8):3089-96
references.pmid: 8605321
references.citation: Oncogene. 2000 Oct 5;19(42):4936-40
references.pmid: 11039911
references.citation: Blood. 2005 Aug 15;106(4):1392-9
references.pmid: 15870177
references.citation: Cell Death Differ. 1999 Jun;6(6):525-32
references.pmid: 10381646